DK1068208T3 - Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem - Google Patents

Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem

Info

Publication number
DK1068208T3
DK1068208T3 DK99909806T DK99909806T DK1068208T3 DK 1068208 T3 DK1068208 T3 DK 1068208T3 DK 99909806 T DK99909806 T DK 99909806T DK 99909806 T DK99909806 T DK 99909806T DK 1068208 T3 DK1068208 T3 DK 1068208T3
Authority
DK
Denmark
Prior art keywords
hydrogen
substituent
azatricyclo
sigma
pharmaceutical compositions
Prior art date
Application number
DK99909806T
Other languages
Danish (da)
English (en)
Inventor
Merouane Bencherif
Patrick Michael Lippiello
Peter Anthony Crooks
Haeil Park
Balwinder Singh Bhatti
William Scott Caldwell
Gary Maurice Dull
Original Assignee
Targacept Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/053,937 external-priority patent/US6057446A/en
Priority claimed from US09/054,175 external-priority patent/US5952339A/en
Application filed by Targacept Inc filed Critical Targacept Inc
Application granted granted Critical
Publication of DK1068208T3 publication Critical patent/DK1068208T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK99909806T 1998-04-02 1999-03-03 Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem DK1068208T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/053,937 US6057446A (en) 1998-04-02 1998-04-02 Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US09/054,175 US5952339A (en) 1998-04-02 1998-04-02 Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
PCT/US1999/004728 WO1999051602A1 (en) 1998-04-02 1999-03-03 Azatricyclo[3.3.1.1] decane derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK1068208T3 true DK1068208T3 (da) 2003-09-01

Family

ID=26732410

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99909806T DK1068208T3 (da) 1998-04-02 1999-03-03 Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem

Country Status (13)

Country Link
EP (1) EP1068208B1 (pt)
JP (1) JP2002510690A (pt)
KR (1) KR100591805B1 (pt)
AT (1) ATE240331T1 (pt)
AU (1) AU2892999A (pt)
BR (1) BR9907172A (pt)
CA (1) CA2317567A1 (pt)
DE (1) DE69907894T2 (pt)
DK (1) DK1068208T3 (pt)
ES (1) ES2199561T3 (pt)
MX (1) MXPA00009634A (pt)
PT (1) PT1068208E (pt)
WO (1) WO1999051602A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432975B1 (en) * 1998-12-11 2002-08-13 Targacept, Inc. Pharmaceutical compositions and methods for use
US6953855B2 (en) 1998-12-11 2005-10-11 Targacept, Inc. 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
MY145722A (en) * 2000-04-27 2012-03-30 Abbott Lab Diazabicyclic central nervous system active agents
US6809105B2 (en) 2000-04-27 2004-10-26 Abbott Laboratories Diazabicyclic central nervous system active agents
WO2001082978A2 (en) * 2000-05-01 2001-11-08 Targacept, Inc. Imaging of nicotinic acetylcholine receptor subtypes
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
ATE538122T1 (de) * 2007-03-23 2012-01-15 Abbott Lab Acetamid- und carboxamid-derivate von azaadamantan sowie verfahren zu ihrer verwendung
EP2139891B1 (en) * 2007-03-23 2012-09-05 Abbott Laboratories 4-substituted azaadamantane derivatives and methods of use thereof
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
PE20131394A1 (es) 2010-09-23 2014-01-11 Abbvie Inc Monohidrato de derivados de aza-adamantano
US9724340B2 (en) 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107184A (en) * 1992-10-09 1997-08-14 Abbott Lab Heterocyclic ether compounds that enhance cognitive function
US5597919A (en) * 1995-01-06 1997-01-28 Dull; Gary M. Pyrimidinyl or Pyridinyl alkenyl amine compounds
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
JP3510937B2 (ja) * 1995-06-05 2004-03-29 ポリプラスチックス株式会社 耐熱性ポリエステルアミドスルフィド樹脂及びその組成物
WO1997001556A1 (en) * 1995-06-29 1997-01-16 Novo Nordisk A/S Novel substituted azacyclic or azabicyclic compounds
JPH11512443A (ja) * 1995-09-22 1999-10-26 ノボ ノルディスク アクティーゼルスカブ 新規な置換アザ環式またはアザ二環式化合物

Also Published As

Publication number Publication date
BR9907172A (pt) 2000-10-10
EP1068208A1 (en) 2001-01-17
DE69907894T2 (de) 2004-03-11
EP1068208B1 (en) 2003-05-14
CA2317567A1 (en) 1999-10-14
KR100591805B1 (ko) 2006-06-26
PT1068208E (pt) 2003-09-30
DE69907894D1 (de) 2003-06-18
ATE240331T1 (de) 2003-05-15
KR20010052173A (ko) 2001-06-25
WO1999051602A1 (en) 1999-10-14
JP2002510690A (ja) 2002-04-09
AU2892999A (en) 1999-10-25
ES2199561T3 (es) 2004-02-16
MXPA00009634A (es) 2005-06-20

Similar Documents

Publication Publication Date Title
AU2003222450A1 (en) Stabilized ascorbic acid derivatives
DK1068208T3 (da) Azatricyclo[3.3.1.1]dekanderivater og farmaceutiske sammensætninger, der indeholder dem
CZ142195A3 (en) Injectable composition containing derivatives of taxan group
HUP0300393A2 (hu) C-aril glükozid SGLT2 inhibitorok és alkalmazásuk, valamint ezeket tartalmazó gyógyszerkészítmények
IL114726A0 (en) Noribogaine derivatives and pharmaceutical compositions containing the same
CA2302445A1 (en) New taxane derivatives
CA2400804A1 (en) Stable emulsion compositions of cycloalkene derivatives
CA2277877A1 (en) Nitric oxide synthase inhibitors
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
WO2004098518A3 (en) Pyrazole-amide compounds useful as kinase inhibitors
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
WO2004071440A3 (en) Thiazolyl-based compounds useful as kinase inhibitors
AU2019502A (en) Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto
DE60320093D1 (de) Uv absorbierende zusammensetzung enthaltend hydroxyphenyltriazinverbindungen
CA2199128A1 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
WO1999009965A3 (en) Anti-inflammatory agent
AU4705200A (en) Cosmetic compositions
TW200517132A (en) Stable aqueous antiplaque oral compositions
DK1066287T3 (da) Azatricykliske forbindelser
WO2002007677A3 (en) Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
IL127379A0 (en) Dihydrobenzopyran and related compounds useful as anti-inflammatory agents
EP1182192A4 (en) 4-HYDROXYPIPERIDINE DERIVATIVES WITH ANTI-ARRHYTHMIC EFFECT
CA2191850A1 (en) Cancerous metastasis inhibitor
AU8889998A (en) Water soluble analogs and prodrugs of paclitaxel
EP0335979A4 (en) Thienopyrimidine derivatives